Oncology Stocks
AZN$39.56-1.03 (-2.54%)
NVS$48.98-0.56 (-1.13%)
SNY$31.11-1.58 (-4.83%)
GSK$36.38-0.59 (-1.6%)

Pancreatic Cancer Information Center

Folder Conference Coverage

People Current Topics



News Latest Pancreatic Cancer News

Neoadjuvant Radiation Improves Survival in Pancreatic Cancer (12/12/2008)
Researchers from the Weill Cornell Medical College have reported that preoperative radiation nearly doubles the survival rate for patients with operable pancreatic cancer. The details of this review were published in the November 15, 2008 issue of the International Journal of Radiation Oncology Biology Physics.

Possible Link between Hepatitis B Virus and Pancreatic Cancer (10/6/2008)
Researchers from the M. D. Anderson Cancer Center in Texas have reported that exposure to the hepatitis B virus may be associated with the development of pancreatic cancer. The study was recently published in the October 1, 2008 issue of the Journal of Clinical Oncology.

EndoTAG-1® Shows Promise in Treatment of Pancreatic Cancer (9/22/2008)
According to the results of a Phase II clinical trial, the addition of the investigational drug EndoTAG-1® to chemotherapy with Gemzar® (gemcitabine) may improve survival among patients with inoperable pancreatic cancer. These results were presented in a late-breaking abstract at the 33rd Congress of the European Society for Medical Oncology (ESMO).

Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers (8/4/2008)
Researchers affiliated with the Cancer Programs, American College of Surgeons, recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic cancers. The results of this study were published in the July 2008 issue of the Archives of Surgery.

Normalization of N-telopeptide Associated with Improved Survival from Bone Metastasis Treated with Bisphosphonates (6/25/2008)
Researchers involved in a multicenter international trial have reported that normalization of N-telopeptide of type I collagen (NTX) levels is associated with skeletal-related events and survival among patients with bone metastases from solid tumors treated with Zometa® (zoledronic acid) or Aredia® (pamidronate). These results were published in the July 1, 2008 issue of Cancer.

More Pancreatic Cancer News »

Pancreatic Cancer Drug Pipeline

What's in the pipeline for Pancreatic Cancer.

Newsletters

Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.


© 1998-2007 OncoEd, Inc.   All Rights Reserved.